Carna Health expands global kidney disease screening on World Kidney Day

US digital health company Carna Health has announced a global expansion of its AI-driven chronic kidney disease (CKD) screening programmes, with Southeast Asia among the key regions targeted as part of the rollout.

The announcement, made to coincide with World Kidney Day, includes new programmes across Latin America, Africa, and Asia, with the Philippines representing the company’s entry point into Southeast Asia.

The Philippines programme spans both private and public healthcare settings across Manila, Quezon City, and the province of Cagayan, with a target of screening more than 300,000 individuals. The initiative combines AI-based risk scoring with point-of-care diagnostics and integration with local health system laboratory platforms. Indonesia is next in line, with an initial pilot targeting 10,000 individuals expected later in 2026.

Carna Health says the expansion addresses a significant gap in structured CKD screening across the region, where the condition frequently goes undiagnosed until it reaches advanced stages. The company’s earlier programmes in Bermuda and Cameroon found that the large majority of those identified with CKD were unaware of their condition prior to screening.

CKD is closely associated with hypertension and diabetes, both of which carry a growing burden across Southeast Asia. Left undetected, the disease can progress to end-stage kidney failure, requiring dialysis or transplant.